constrained macrocycle design

Kissaki Biosciences is using novel approaches to advance new oral peptide-based therapeutics, focusing on high value, validated targets in immunology and inflammation (I&I), with particular interest in gastrointestinal disorders such as inflammatory bowel disease (IBD). The team leverages decades of peptide engineering and drug development expertise to accelerate treatments into and through the clinic.

Read more

AI modelingbio-panningdrug developmentpeptide engineeringstructural biology